Clinical trial
Evaluation the Effect of Topically Coated Dental Implants With 1% Metformin Gel on Osteointegration and Crestal Marginal Bone Loss (a Randomized Controlled Clinical Trial)
NCT06031168 is registered in ClinicalTrials.gov with Hams Hamed Abdelrahman as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation the Effect of Topically Coated Dental Implants With 1% Metformin Gel on Osteointegration and Crestal Marginal Bone Loss (a Randomized Controlled Clinical Trial)
- Lead sponsor
- Hams Hamed Abdelrahman
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 4, 2023
- Completion date
- November 30, 2023
- Enrollment
- 26 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
osteointegration